Trademark Overview
On Tuesday, January 23, 2024, a trademark application was filed for QURE with the United States Patent and Trademark Office. The USPTO has given the QURE trademark a serial number of 98371742. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, November 5, 2024. This trademark is owned by uniQure IP B.V.. The QURE trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Viral systems, gene therapy systems, nucleic acid delivery systems, all comprised of biological preparations in the nature of viruses for medical purposes; viral vectors, gene therapy vectors, nucleic acid delivery vectors, all comprised of biological preparations in the nature of viruses for medical purposes; pharmaceutical products for the treatment of diseases; biological preparations for use in medical purposes, namely, in medical and clinical gene therapy, nucleic acid-based therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, gene diagnosis and gene testing; pharmaceutical preparations being prophylaxis products for use in nucleic acid-based therapy and gene therapy
Viral systems, gene therapy systems, and nucleic acid delivery systems, all comprised of biological preparations in the nature of viruses for use in cell cultures for non-medical, scientific research purposes; viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors all comprised of biological preparations in the nature of viruses for use in cell cultures for non-medical, scientific research purposes
Medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders using gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation; Providing medical information and advice in the field of medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders using gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation
Medical and scientific research, product development and consultancy in the fields of biotechnology, biology, biopharmaceutical research and development, medical science, chemistry and biochemistry; Providing medical and scientific research information and advice in the fields of biotechnology, biology, biopharmaceutical research and development, medical science, chemistry and biochemistry
